ARBOR HEALTH TECHNOLOGIES INC.
GIFTS, MEALS, AND ENTERTAINMENT POLICY
Policy Number: AHT-COMP-005 (Revised) Effective Date: July 1, 2023 Supersedes: Prior Gifts and Entertainment Policy (undated) Approved By: AHT Board Compliance Committee, June 27, 2023 Policy Owner: Derek Huang, Chief Compliance Officer Legal Review: Calderwood & Harkness LLP (Matter No. 1010-00003) Next Review Date: July 1, 2024
Right-click to update Table of Contents
I. PURPOSE AND BACKGROUND
The purpose of this Gifts, Meals, and Entertainment Policy (this "Policy") is to establish clear, comprehensive, and enforceable standards governing the giving and receiving of gifts, meals, entertainment, educational sponsorships, travel, and other items of value between Arbor Health Technologies Inc. ("AHT" or the "Company") personnel and referral sources, vendors, pharmaceutical and medical device representatives, and other third parties. This Policy is designed to ensure that all such interactions are conducted in a manner that is lawful, ethical, transparent, and consistent with the Company's commitment to regulatory compliance and patient-centered care.
AHT operates in a highly regulated healthcare environment in which the exchange of items of value between healthcare providers, referral sources, and vendors is subject to extensive federal and state laws and regulations. These include, but are not limited to, the following:
(a) The federal Anti-Kickback Statute ("AKS"), 42 U.S.C. § 1320a-7b(b), which prohibits the knowing and willful offering, paying, soliciting, or receiving of remuneration to induce or reward referrals for items or services payable by federal healthcare programs;
(b) The Physician Self-Referral Law ("Stark Law"), 42 U.S.C. § 1395nn, which prohibits a physician from making referrals for certain designated health services to an entity with which the physician (or an immediate family member) has a financial relationship, unless an exception applies;
(c) The Stark Law non-monetary remuneration exception, 42 C.F.R. § 411.357(k), which permits limited non-monetary compensation from an entity to a referring physician, subject to an annual aggregate dollar threshold adjusted each calendar year by the Consumer Price Index;
(d) The Office of Inspector General ("OIG") Compliance Guidance for Individual and Small Group Physician Practices, 65 Fed. Reg. 59434, which provides guidance on compliance program elements and risk areas including gifts and items of value;
(e) The Massachusetts state anti-kickback law, M.G.L. c. 175H, § 3, which extends kickback prohibitions beyond federal healthcare programs to cover all payer types in the Commonwealth of Massachusetts; and
(f) The Connecticut referral fee prohibition, Conn. Gen. Stat. § 20-7a(d), which restricts fee-splitting and referral payments involving licensed practitioners in the State of Connecticut.
The importance of rigorous compliance with these laws cannot be overstated. In Fiscal Year 2022 ("FY2022"), AHT reported $214.3 million in net revenue, of which approximately sixty-one percent (61%), or $130.7 million, was derived from Medicare and Medicaid reimbursements administered by the Centers for Medicare & Medicaid Services ("CMS"). This substantial reliance on federal healthcare program revenue makes AKS and Stark Law compliance critically important to the Company's financial integrity, continued participation in federal healthcare programs, and protection against civil and criminal liability.
This Policy has been developed in response to, and informed by, the following specific assessments and engagements:
(a) Grayson Whitaker & Associates LLP Compliance Gap Assessment. In December 2022, Grayson Whitaker & Associates LLP completed a comprehensive compliance gap assessment of AHT's existing compliance program (Report GW-AHT-2022-Final, dated December 12, 2022). That assessment identified several areas of concern relating to vendor-provided items of value, including but not limited to the no-cost electronic laboratory interface provided by Pinnacle Laboratory Services Inc. ("Pinnacle") integrated into the Company's ArborConnect clinical platform, as well as multiple continuing medical education ("CME") sponsorships funded by Pinnacle and other entities with active referral relationships with AHT.
(b) Calderwood & Harkness LLP Self-Assessment Engagement. Following the Grayson Whitaker gap assessment, the Company engaged Calderwood & Harkness LLP on January 30, 2023, to conduct a targeted self-assessment of AHT's gift, meal, entertainment, and vendor arrangement practices. That engagement was completed on July 12, 2023, and resulted in a recommendation that the Company adopt this revised Policy, together with a suite of companion policies and remediation action plans.
(c) AHT Compliance Committee Charter. This Policy is adopted pursuant to the authority of the AHT Board Compliance Committee as set forth in the AHT Compliance Committee Charter (adopted April 15, 2021; amended October 30, 2022), which charges the Board Compliance Committee with oversight of the Company's compliance program, including the adoption and periodic revision of compliance policies and procedures.
All AHT personnel are expected to read, understand, and comply with this Policy. Violations may result in disciplinary action, including termination of employment or contractor engagement, and may also give rise to personal civil and criminal liability under applicable federal and state law.
II. SCOPE AND APPLICABILITY
A. Covered Personnel
This Policy applies to all individuals who perform services for, on behalf of, or at the direction of Arbor Health Technologies Inc., regardless of their employment classification, title, or location. Covered personnel include, without limitation, the following categories:
(a) All AHT Employees. This Policy applies to all approximately 1,340 total employees of AHT, including all clinical and administrative personnel employed at any AHT facility, clinic, or administrative office.
(b) Employed Physicians. All 147 W-2 employed physicians across AHT's 23 outpatient clinic locations in the Commonwealth of Massachusetts (14 clinics), the State of Connecticut (4 clinics), the State of Rhode Island (3 clinics), and the State of New Hampshire (2 clinics) are subject to this Policy.
(c) Independent Contractors and Medical Directors. All 38 independent contractors and medical directors who provide clinical, administrative, or advisory services to AHT under contract are covered by this Policy. Compliance with this Policy shall be incorporated as a material term of all independent contractor and medical director agreements, and failure to comply shall constitute grounds for termination of such agreements.
(d) Acquired Physicians and Staff. All physicians and staff acquired from Lakeview Medical Associates, P.C. (14 physicians integrated via the August 15, 2022 acquisition) are subject to this Policy to the same extent as all other AHT employed physicians.
(e) Regional and Facility-Level Leadership. All regional and facility-level leaders, including Dr. Vivian Chao, Regional Medical Director (Central Massachusetts), and all other individuals holding regional medical director, clinic director, or similar leadership titles, are subject to this Policy.
(f) Officers and Directors. All officers and directors of AHT, including Dr. Nathan Ellsworth (Chief Executive Officer), Patricia Yamamoto (General Counsel), and Derek Huang (Chief Compliance Officer), are subject to this Policy without exception.
(g) ConnectiCare Physicians Network, LLC Personnel. All personnel of ConnectiCare Physicians Network, LLC who act on AHT's behalf in managing the 9 independently owned physician practices in Strathmore Mutual Insurance, Connecticut area are subject to this Policy to the extent they are acting within the scope of AHT's management services arrangement.
For the avoidance of doubt, no individual's seniority, title, or position within the Company exempts that individual from compliance with this Policy. The standards set forth herein apply uniformly to all covered personnel.
B. Covered Third Parties and Interactions
This Policy governs interactions between AHT covered personnel and the following categories of third parties:
(a) Referral Sources. Any physician, hospital, laboratory, diagnostic company, or other healthcare provider that is in a position to make or influence referrals of patients, specimens, or items or services payable by Medicare, Medicaid, or other federal healthcare programs to AHT or its affiliates. This category includes, but is not limited to, referring physicians, hospitals with which AHT has transfer or discharge relationships, and other provider organizations.
(b) Vendors. Pharmaceutical companies, medical device manufacturers, information technology vendors, supply companies, and any other company or individual providing goods, services, or items of value to AHT.
(c) Laboratories. All clinical and reference laboratories with which AHT has a referral or business relationship, including specifically Pinnacle Laboratory Services Inc., headquartered at 1200 Warwick Avenue, Suite 110, Warwick, Rhode Island 02886.
(d) Diagnostic Imaging Providers. All diagnostic imaging providers with which AHT has a referral or business relationship, including specifically Meridian Diagnostics LLC.
(e) Commercial Payers. All commercial insurance carriers and managed care organizations with which AHT participates, including specifically Covenant Health Plans Inc.
(f) Pharmaceutical and Device Representatives. All representatives of pharmaceutical, biotechnology, and medical device companies who seek to interact with AHT physicians or clinical staff.
(g) Consultants and Professional Service Providers. All third-party consultants, advisors, and professional service providers engaged by AHT, to the extent that such engagements involve the exchange of items of value relevant to this Policy.
C. Geographic Applicability
This Policy applies to all AHT operations across the Commonwealth of Massachusetts, the State of Connecticut, the State of Rhode Island, and the State of New Hampshire. AHT covered personnel are required to comply with this Policy at all times, regardless of the physical location in which an interaction occurs.
In addition to the federal requirements described herein, state-specific restrictions on gifts, meals, entertainment, and items of value may apply in each jurisdiction in which AHT operates. Where a state law imposes a more restrictive standard than this Policy or federal law, the more restrictive standard governs. State-specific requirements are discussed in further detail in Section X of this Policy.
III. DEFINITIONS
A. Key Terms
For purposes of this Policy, the following terms have the meanings set forth below:
"Gift" means any item of value provided to or received from a third party, including but not limited to tangible goods, gift cards, tickets, technology, software, equipment, and services provided at no cost or below fair market value. The term "Gift" shall be construed broadly to include any transfer of value that could be perceived as an inducement or reward for referrals or business arrangements, regardless of the form in which the value is conveyed.
"Meal" means food and beverage provided in connection with a business interaction, educational event, or professional meeting. This includes breakfast, lunch, dinner, receptions, snacks, and any other provision of food or drink, whether in a restaurant, at a hotel, at an AHT facility, or at any other location.
"Entertainment" means social or recreational activities, including but not limited to sporting events, golf outings, concerts, theater performances, recreational outings, spa treatments, fishing trips, and similar activities. Entertainment does not include bona fide educational events or meetings at which substantive clinical or business content is the primary purpose.
"Referral Source" means any person or entity that is in a position to make or influence referrals of patients, specimens, or items or services payable by Medicare, Medicaid, or other federal healthcare programs to AHT or its affiliates. A referral source includes, without limitation, a physician, a hospital, a clinical laboratory, a diagnostic imaging provider, a home health agency, a skilled nursing facility, a durable medical equipment supplier, or any other entity or individual that directs or could direct the flow of patients or healthcare business to AHT. An entity may be both a vendor and a referral source; in such cases, the more restrictive referral source standards apply.
"Non-Monetary Remuneration" means items or services received by a physician (or an immediate family member of a physician) from an entity that does not constitute cash or cash-equivalent compensation. Non-monetary remuneration is subject to the Stark Law annual aggregate limit of $459 per physician per calendar year (CY2023), as adjusted annually by the Consumer Price Index ("CPI") pursuant to 42 C.F.R. § 411.357(k). The Company's compliance office will publish the updated threshold each January, promptly following CMS's publication of the adjusted amount.
"Vendor" means any company or individual providing goods, services, or items of value to AHT, including but not limited to pharmaceutical companies, medical device manufacturers, information technology vendors, office supply companies, consulting firms, staffing agencies, and construction or facilities management contractors.
"Immediate Family Member" means, as defined under the Stark Law at 42 C.F.R. § 411.351, the spouse, natural or adoptive parent, child or sibling, stepparent, stepchild, stepbrother or stepsister, in-law (father-in-law, mother-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law), grandparent, grandchild, and spouse of a grandparent or grandchild.
"Continuing Medical Education (CME)" means educational activities that are accredited by an Accreditation Council for Continuing Medical Education ("ACCME")-accredited provider, or by a state medical society recognized by the ACCME for the purpose of awarding CME credit.
"Fair Market Value (FMV)" means the value in arm's-length transactions, consistent with the general market value of the subject transaction, as defined under 42 C.F.R. § 411.351. Fair market value is the compensation that would be paid at the time of the transaction by a willing buyer to a willing seller, with neither being under compulsion to buy or sell and both having reasonable knowledge of relevant facts. With respect to rentals or leases, fair market value means the value of the rental property for general commercial purposes, not taking into account its intended use for purposes of referral.
"ArborConnect" means AHT's proprietary electronic health record and clinical practice management platform.
"Federal Healthcare Program" means any plan or program that provides health benefits, whether directly, through insurance, or otherwise, that is funded directly, in whole or in part, by the United States Government, including Medicare, Medicaid, TRICARE, and the Children's Health Insurance Program, as defined under 42 U.S.C. § 1320a-7b(f).
IV. REGULATORY FRAMEWORK
This Section provides an overview of the principal federal and state laws and regulations that form the legal basis for this Policy. All AHT covered personnel should be familiar with these legal requirements, and should direct questions regarding their application to the Chief Compliance Officer or General Counsel.
A. Federal Anti-Kickback Statute (42 U.S.C. § 1320a-7b(b))
The federal Anti-Kickback Statute prohibits any person from knowingly and willfully offering, paying, soliciting, or receiving any remuneration (including any kickback, bribe, or rebate), directly or indirectly, overtly or covertly, in cash or in kind, to induce or reward referrals of individuals for the furnishing of items or services payable by a federal healthcare program.
The AKS is broadly construed. Under the "one-purpose test" established by federal courts, if even one purpose of the remuneration is to induce or reward referrals for items or services reimbursable by a federal healthcare program, the arrangement may violate the AKS, regardless of whether there are other, legitimate purposes for the payment or exchange of value.
Violations of the AKS carry significant penalties, including:
(a) Criminal penalties of up to five (5) years' imprisonment and fines of up to $100,000 per violation (felony);
(b) Civil monetary penalties of up to $100,000 per violation;
(c) Treble damages under the federal False Claims Act;
(d) Mandatory exclusion from participation in all federal healthcare programs; and
(e) Liability under the federal False Claims Act, 31 U.S.C. §§ 3729–3733, to the extent that claims submitted to federal healthcare programs are tainted by an AKS violation (pursuant to 42 U.S.C. § 1320a-7b(g), a claim that includes items or services resulting from an AKS violation constitutes a false or fraudulent claim for purposes of the False Claims Act).
Gifts, meals, entertainment, free or below-market-value items or services, and other items of value provided to or received from referral sources, vendors, or pharmaceutical and device representatives may constitute prohibited remuneration under the AKS. The AKS applies regardless of the dollar amount of the remuneration at issue, and there is no de minimis exception under the statute itself.
B. Stark Law Non-Monetary Remuneration Exception (42 C.F.R. § 411.357(k))
The Stark Law prohibits a physician from making referrals for designated health services to an entity with which the physician (or an immediate family member of the physician) has a financial relationship, unless an applicable exception is met. One such exception is the non-monetary remuneration exception at 42 C.F.R. § 411.357(k).
Under this exception, non-monetary compensation from an entity to a physician who is in a position to make referrals to the entity is permissible if the following conditions are satisfied:
(a) The aggregate value of the non-monetary compensation does not exceed $459 per physician per calendar year (CY2023), as adjusted annually by the CPI;
(b) The compensation is not determined in a manner that takes into account the volume or value of referrals or other business generated between the parties;
(c) The compensation is not solicited by the physician or the physician's practice; and
(d) For items exceeding nominal value, the items are used solely for the physician's medical practice purposes.
This exception provides a narrow safe harbor for modest items of value. It is essential to note that the $459 annual aggregate limit applies per physician, per referring entity, per calendar year. All items of value received by a physician from a single entity must be tracked and aggregated, and the total must not exceed the applicable annual threshold.
As identified in the Grayson Whitaker gap assessment and the Calderwood & Harkness self-assessment, the no-cost electronic laboratory interface provided by Pinnacle Laboratory Services Inc. to AHT and integrated into ArborConnect has an estimated fair market value of approximately $120,000 per year. This amount vastly exceeds the $459 annual per-physician limit and cannot qualify under the non-monetary remuneration exception. The Pinnacle arrangement requires immediate restructuring, as discussed in further detail in Sections VII.C and IX.C of this Policy.
C. AKS Safe Harbor Modernization and Stark Law Modernization (2021)
On November 20, 2020, CMS and the OIG published final rules modernizing the Stark Law exceptions and AKS safe harbors, respectively, with an effective date of January 19, 2021. The CMS Final Rule (85 Fed. Reg. 77492) established new and modified Stark Law exceptions for value-based arrangements, and the OIG Final Rule (85 Fed. Reg. 77684) established new and modified AKS safe harbors for value-based arrangements and other payment structures.
These modernized exceptions and safe harbors may apply to certain quality-metric-based incentive payments and value-based care arrangements. For example, value-based incentive bonuses received by AHT from Covenant Health Plans Inc. (totaling approximately $2.1 million in FY2022) may be analyzed under these frameworks. However, the value-based arrangement exceptions and safe harbors do not broadly exempt gifts, meals, entertainment, or other items of value from AKS and Stark Law scrutiny. Such items must continue to be evaluated under the specific provisions of this Policy and the applicable law.
D. OIG Guidance
The Office of Inspector General of the U.S. Department of Health and Human Services has published extensive guidance relevant to the exchange of items of value between healthcare providers, referral sources, and vendors. Key publications include:
(a) OIG Compliance Guidance for Individual and Small Group Physician Practices (65 Fed. Reg. 59434), which identifies gifts and other inducements to referral sources as a core risk area and recommends that physician practices implement policies to monitor and control such interactions;
(b) OIG Special Advisory Bulletins, including bulletins addressing the offering of items of value to federal healthcare program beneficiaries and the provision of free or below-market-value goods and services to referral sources; and
(c) OIG Fraud Alerts, including alerts concerning laboratory and diagnostic company marketing practices that involve the provision of free equipment, technology, or services to referring physicians or physician groups.
The OIG has consistently advised that items of even nominal value, when aggregated over time or systematically provided to referral sources, can form the basis of an AKS enforcement action. The OIG has made clear that it will examine the totality of the circumstances, including the pattern and practice of providing items of value, the relationship between the item of value and any referral arrangement, and the aggregate value of all items provided over time.
V. DOLLAR THRESHOLDS AND LIMITS
A. Per-Occurrence and Annual Aggregate Limits
This Section establishes the specific dollar thresholds and limits applicable to each category of gift, meal, entertainment, and other item of value governed by this Policy. All dollar amounts are stated in United States dollars. Where applicable, annual aggregate limits are aligned with the Stark Law non-monetary remuneration exception threshold, which is adjusted annually by CMS.
1. Gifts To/From Referral Sources
(a) Per-Item Limit. No single gift to or from a referral source shall exceed $25.00 in value (or estimated fair market value, if not purchased).
(b) Annual Aggregate Limit. The aggregate value of all gifts, meals, and other items of value exchanged with any single referral source (or any single physician associated with a referral source) shall not exceed $459 per calendar year (CY2023). This threshold is aligned with the Stark Law non-monetary remuneration exception, as adjusted annually by the CPI. The AHT compliance office will publish the updated threshold each January, promptly following CMS's publication of the adjusted amount.
(c) Business or Medical Practice Purpose. All gifts to or from referral sources must be of a type that serves a legitimate business or medical practice purpose. Gifts of a purely personal nature (e.g., luxury items, personal electronics unrelated to medical practice) are not permitted.
(d) No Cash or Cash Equivalents. Cash or cash-equivalent gifts — including but not limited to gift cards, store credits, prepaid debit cards, and cryptocurrency — are prohibited at any dollar value. There is no exception to this prohibition.
2. Meals.
(a) Per-Person Meal Limit (Referral Sources and Vendors). Business meals with referral sources or vendors shall not exceed $50.00 per person per occasion. This limit includes the cost of food, beverages, tax, and gratuity attributable to each individual attendee.
(b) Legitimate Business Purpose. All meals must have a legitimate, documented business purpose and must be modest in nature. Lavish or extravagant meals are prohibited, regardless of whether the per-person cost falls within the dollar threshold.
(c) Annual Aggregate Tracking. All meal spending with referral sources is tracked toward the $459 annual non-monetary remuneration limit applicable to the relationship with each referral source. AHT covered personnel must ensure that meal expenses, when combined with all other items of value exchanged with the referral source, do not cause the annual aggregate to exceed the applicable threshold.
(d) Group Meals at Bona Fide Educational Events. Group meals provided at bona fide educational events, including ACCME-accredited CME programs, may not exceed $75.00 per person per event. Such meals are subject to the additional CME-specific requirements set forth in Section VII of this Policy.
3. Gifts To/From Vendors (Non-Referral Sources)
(a) Per-Item Limit. No single gift to or from a vendor that is not a referral source shall exceed $100.00 in value.
(b) Annual Aggregate Limit. The aggregate value of all gifts exchanged with any single non-referral-source vendor shall not exceed $250.00 per calendar year.
(c) General Utility. Items must be of general utility and must not be targeted to influence purchasing decisions for items or services reimbursable by federal healthcare programs. Items of general utility include office supplies, educational materials, and similar items used in the ordinary course of medical or administrative practice.
(d) Dual-Status Entities. If a vendor is also a referral source (or is in a position to make or influence referrals), the more restrictive referral source standards set forth in Section V.A.1 apply to all interactions with that vendor, regardless of the nature of the specific transaction.
4. Entertainment.
(a) Referral Sources. Entertainment involving referral sources is prohibited as a general matter, as set forth in Section VI of this Policy. No dollar threshold applies because the activity itself is not permitted.
(b) Vendors (Non-Referral Sources). Entertainment involving vendors that are not referral sources requires prior written approval from both the Chief Compliance Officer and the General Counsel. Even with such approval, the cost of entertainment shall not exceed $150.00 per person per occasion. All entertainment expenses must be documented and reported.
B. Tracking Toward Annual Limits
Effective compliance with this Policy requires accurate and contemporaneous tracking of all items of value exchanged between AHT covered personnel and third parties. The following tracking requirements apply:
(a) Centralized Tracking Log. All items of value given to or received from referral sources, including gifts, meals, entertainment (where permitted), CME sponsorships, technology, software, equipment, and services, must be logged in the centralized Non-Monetary Remuneration Tracking Log maintained by the Office of the Chief Compliance Officer (Derek Huang). Instructions for accessing and using the tracking log are available on the AHT compliance intranet and in the Non-Monetary Remuneration and Compliance Exception Tracking Protocol (AHT-COMP-009).
(b) Per-Physician Monitoring. Each physician's cumulative annual total of non-monetary remuneration received from each entity with which the physician has a referral relationship will be monitored against the $459 annual threshold. The CCO's office will issue alerts to physicians and their supervisors when cumulative totals reach eighty percent (80%) of the annual threshold.
(c) Single-Item Threshold. If a single item or service provided at no cost to AHT or to an AHT physician has a fair market value that exceeds $459 in a single instance, it cannot qualify under the Stark Law non-monetary remuneration exception, regardless of how infrequently it is provided. Such items require immediate review and restructuring under Section IX.C of this Policy.
VI. ENTERTAINMENT POLICY
A. General Prohibition with Referral Sources
AHT personnel shall not provide entertainment to referral sources or their immediate family members. This prohibition includes, without limitation, tickets to sporting events, golf outings, concert tickets, theater tickets, recreational excursions, spa treatments, hunting or fishing trips, and any other social or recreational activities.
AHT personnel shall not accept entertainment from referral sources. This prohibition applies regardless of whether a business discussion occurs during the event, regardless of the dollar value of the entertainment, and regardless of whether the entertainment is characterized as a token of appreciation, a relationship-building activity, or an industry-standard practice.
The rationale for this prohibition is straightforward: the provision of entertainment to referral sources creates a significant risk that the entertainment will be viewed as remuneration intended to induce or reward referrals, in violation of the AKS. The OIG has repeatedly identified entertainment of referral sources as a high-risk practice, and the Company has determined that the compliance risks associated with such activities outweigh any potential business benefits.
B. Limited Exception for Internal AHT Events
AHT-sponsored internal events, such as employee appreciation events, holiday parties, team-building activities, and similar gatherings, at which referral sources may be incidentally present, are permissible, provided the following conditions are met:
(a) The event is open to all AHT personnel at a given location and is not specifically designed or intended to entertain referral sources or to recognize or reward referral relationships;
(b) The cost per attendee (including food, beverage, and any entertainment component) does not exceed $75.00; and
(c) The event is documented in the Non-Monetary Remuneration Tracking Log to the extent that referral sources attend.
C. Vendor-Sponsored Entertainment
AHT personnel may not accept vendor-sponsored entertainment that is linked, directly or indirectly, to the purchase, lease, recommendation, or use of products or services that are reimbursable by federal healthcare programs. This prohibition applies regardless of the dollar value of the entertainment and regardless of whether the vendor is also a referral source.
Vendor-sponsored entertainment that is entirely unrelated to healthcare products or services (for example, a vendor appreciation event hosted by an office supply company) requires prior written approval from the Chief Compliance Officer. Even where approved, all applicable dollar thresholds and documentation requirements must be observed.
VII. CONTINUING MEDICAL EDUCATION (CME) AND EDUCATIONAL SPONSORSHIPS
A. General Principles
Continuing medical education is vital to the professional development of AHT's physicians and clinical staff, and the Company encourages participation in high-quality CME activities. However, the intersection of CME sponsorship and referral relationships presents significant compliance risks, particularly under the AKS and Stark Law.
The following general principles govern CME activities under this Policy:
(a) CME activities must be accredited by an ACCME-accredited provider. Non-accredited educational programs do not qualify for the more favorable treatment afforded to CME under this Policy and are subject to the general gift and meal thresholds.
(b) AHT physicians may attend CME events sponsored by third parties, provided that the sponsorship is independent, objective, and free from commercial bias. The content of CME programs must be determined by qualified educators and clinicians, not by the sponsoring entity.
(c) CME sponsorship must not be conditioned on referrals, purchasing decisions, or any other business arrangement between AHT and the sponsoring entity. Any express or implied quid pro quo between CME sponsorship and business activity is prohibited.
B. Third-Party CME Sponsorship of AHT Events
Third parties may provide unrestricted educational grants to fund CME events for AHT physicians, subject to the following conditions:
(a) The grant must be made to AHT as an organization, not to individual physicians or physician groups. Individual physicians may not solicit or accept direct CME sponsorship payments from third parties.
(b) AHT — not the sponsor — must control all aspects of the educational content, including topic selection, faculty selection, presentation format, and learning objectives. The sponsor shall have no role in determining or influencing the educational content of the program.
(c) The sponsor receives no influence over educational content, speaker selection, or attendee lists. The sponsor may be acknowledged in program materials, but such acknowledgment must be limited to a factual statement of the sponsor's financial support.
(d) The grant must be documented in a written agreement between AHT and the sponsor, specifying the purpose, amount, and terms of the grant. The written agreement must be reviewed and approved by the CCO (and, where the sponsor is also a referral source, by the General Counsel) prior to execution.
(e) The value of the grant is not tracked as remuneration to individual physicians, provided the event is open to all eligible AHT physicians at a given location and the grant is made to AHT as an organization rather than for the benefit of specific individuals.
C. Specific Concern: Pinnacle Laboratory CME Sponsorship
The Grayson Whitaker & Associates LLP compliance gap assessment (Report GW-AHT-2022-Final) and the Calderwood & Harkness LLP self-assessment identified the following facts concerning CME sponsorships from Pinnacle Laboratory Services Inc.:
(a) Pinnacle sponsored four (4) CME events for AHT physicians in FY2022, with a combined sponsorship value totaling $86,000.
(b) These sponsorships were provided in the context of a preferred laboratory agreement between AHT and Pinnacle (dated June 15, 2020), under which AHT clinics in Rhode Island and southeastern Massachusetts referred approximately $1.65 million in outpatient laboratory work to Pinnacle in FY2022.
(c) In addition to CME sponsorship, Pinnacle provides AHT with a $0.00-cost electronic laboratory interface integrated into the ArborConnect platform. Independent valuation estimates the fair market value of this interface at approximately $120,000 per year.
(d) The combination of CME sponsorship ($86,000), the no-cost laboratory interface ($120,000/year estimated FMV), and the substantial referral volume ($1.65 million in FY2022) creates a heightened risk of AKS and Stark Law violations. The OIG has specifically identified the provision of free or below-market-value technology and CME sponsorship by laboratories to referring physicians and physician groups as a high-priority enforcement area.
In light of these findings, the following requirements apply on a going-forward basis:
(a) CME sponsorships from entities with active referral relationships with AHT must be reviewed and approved by both the CCO and General Counsel prior to acceptance.
(b) CME sponsorship agreements with any entity that is also a referral source must include a written provision expressly separating the educational sponsorship from any referral or business arrangement between the parties. The written agreement must affirm that the sponsorship is not conditioned on the volume or value of referrals, and must include a provision permitting either party to terminate the sponsorship without affecting the underlying referral or business relationship.
(c) All such agreements must be pre-approved in accordance with the procedures set forth in Section IX of this Policy.
D. AHT-Paid CME and Travel for Physicians
AHT may fund the attendance of its employed physicians and contracted medical directors at external CME events where attendance is related to the physician's clinical or administrative duties at AHT. The following requirements apply:
(a) Registration fees must be reasonable and consistent with the standard registration fees charged by the CME provider.
(b) Travel expenses, including airfare, ground transportation, and lodging, must be reasonable, economy-class, and fully documented. Business-class or first-class airfare is not reimbursable absent prior written approval from the CCO for extenuating circumstances (e.g., travel exceeding eight hours in duration).
(c) Lodging must be at reasonable, standard-rate hotel accommodations at or near the event venue. Resort upgrades, premium suites, and similar luxury accommodations are not reimbursable.
(d) No reimbursement for spousal or family member travel, lodging, meals, or incidental expenses is permitted. AHT funds may not be used to subsidize any costs attributable to non-AHT personnel.
VIII. PHARMACEUTICAL AND MEDICAL DEVICE REPRESENTATIVE INTERACTIONS
A. On-Site Representative Visits
Pharmaceutical and medical device representatives play a role in providing information about products relevant to patient care. However, interactions with such representatives must be carefully managed to ensure compliance with applicable law and this Policy. The following requirements apply:
(a) Appointment Required. Pharmaceutical and device representatives may visit AHT clinic locations only by appointment. Walk-in visits are not permitted. Appointments must be scheduled through the clinic's designated representative coordinator or office manager.
(b) Designated Hours. Representative visits are permitted only during designated hours established by each clinic location, which shall generally be limited to non-patient-care hours or designated lunch periods, as determined by the clinic director or regional medical director.
(c) Meal Limits. Representatives may provide meals to AHT clinical staff or physicians in connection with a scheduled visit, provided the meal does not exceed $25.00 per person. This limit is more restrictive than the general business meal limit set forth in Section V.A.2 and reflects the heightened scrutiny applied to pharmaceutical and device company interactions.
(d) Prohibited Items. Representatives may not distribute branded non-educational items of any value, including but not limited to branded pens, mugs, notepads, clothing, tote bags, or similar promotional merchandise. All items provided by representatives must be of genuine educational or patient-care value, such as peer-reviewed clinical literature, patient education materials, or anatomical models for patient consultation purposes.
B. Product Samples
(a) Drug Samples. Prescription drug samples provided by pharmaceutical representatives must be managed in compliance with the Prescription Drug Marketing Act of 1987 (21 U.S.C. § 353), applicable FDA regulations, and AHT's separate Sample Management Policy (AHT-CLIN-012). Drug samples must be stored securely, inventoried regularly, and dispensed only by authorized prescribers in accordance with applicable law.
(b) Device Samples and Loaners. Medical device samples or loaner equipment must be documented, time-limited (not to exceed thirty (30) days without CCO approval), and either returned to the manufacturer or purchased at fair market value at the conclusion of the evaluation period. Device samples may not be retained indefinitely or used as a substitute for purchasing decisions.
C. Speaker Programs and Consulting Arrangements
(a) Pre-Approval. Physician participation in vendor-sponsored speaker programs, advisory boards, consulting engagements, or similar compensated arrangements must be pre-approved by both the CCO and General Counsel prior to the physician's participation.
(b) Fair Market Value Compensation. Compensation for such arrangements must be at fair market value as determined in accordance with the AHT Fair Market Value Determination Procedures (AHT-COMP-008). Compensation that exceeds fair market value may constitute prohibited remuneration under the AKS and Stark Law.
(c) Documentation. All speaker and consulting arrangements must be documented in a written agreement specifying the services to be provided, the compensation, and the term of the arrangement. The written agreement must include a provision affirming that the arrangement is not conditioned on the volume or value of referrals.
(d) Cross-Reference to Other Policies. Such arrangements are also subject to the requirements of the Revised Physician Compensation Policy (AHT-COMP-003) and the Revised Vendor and Third-Party Arrangement Policy (AHT-COMP-006). In the event of a conflict between this Policy and those companion policies, the more restrictive standard governs.
IX. APPROVAL AND PRE-CLEARANCE REQUIREMENTS
This Section establishes a tiered approval framework designed to ensure appropriate oversight of all gifts, meals, entertainment, and items of value governed by this Policy. The approval tiers are structured to provide flexibility for low-risk, routine interactions while requiring progressively more senior review for higher-risk activities.
A. Items Requiring No Pre-Approval (Tier 1)
The following items and interactions may be undertaken without prior approval, provided they are properly documented in the Non-Monetary Remuneration Tracking Log:
(a) Gifts to or from referral sources with a per-item value of $10.00 or less and a cumulative annual aggregate of $50.00 or less per referral source (e.g., branded pens, notepads, or similar items of nominal value used in the ordinary course of medical practice);
(b) Modest refreshments provided at bona fide on-site business meetings, including coffee, water, tea, and light snacks, not exceeding $15.00 per person per meeting.
Even where no pre-approval is required, AHT personnel must exercise judgment and ensure that the item or refreshment serves a legitimate business purpose and does not create even the appearance of impropriety. If there is any doubt regarding the propriety of a Tier 1 interaction, the AHT employee or physician should consult the CCO before proceeding.
B. Items Requiring CCO Pre-Approval (Tier 2)
The following items and interactions require prior written approval from the Chief Compliance Officer (Derek Huang) before they may be undertaken:
(a) Any gift or item of value to or from a referral source with a per-item value between $10.01 and $25.00;
(b) Business meals with referral sources where the per-person cost exceeds $25.00 (up to the maximum per-person limit of $50.00 set forth in Section V.A.2);
(c) Any CME sponsorship received from a third party that is also a referral source, regardless of the dollar amount of the sponsorship;
(d) Any item of value from a laboratory, diagnostic imaging company, or other entity with which AHT has an active referral relationship, regardless of the dollar amount.
Requests for CCO pre-approval should be submitted using the Pre-Approval Request Form available on the AHT compliance intranet. The CCO will endeavor to respond to pre-approval requests within three (3) business days. In time-sensitive situations, the CCO may provide verbal pre-approval, to be followed by written confirmation within five (5) business days.
C. Items Requiring CCO and General Counsel Joint Approval (Tier 3)
The following items and interactions require prior written approval from both the Chief Compliance Officer and the General Counsel (Patricia Yamamoto) before they may be undertaken:
(a) Any entertainment involving non-referral-source vendors where the per-person cost exceeds $100.00 (up to the maximum per-person limit of $150.00 set forth in Section V.A.4);
(b) Any proposed receipt of technology, software, equipment, or services at no cost or below fair market value from a referral source. It is specifically noted that the Pinnacle Laboratory Services Inc. no-cost electronic laboratory interface, with an estimated fair market value of $120,000 per year, requires immediate restructuring rather than approval under this Policy. The Pinnacle arrangement cannot be approved under this tier and is instead governed by the Pinnacle-specific compliance action plan referenced in Section XV.C;
(c) Any item or arrangement that may aggregate with other items of value to cause the cumulative annual non-monetary remuneration total for a given referral source to exceed or approach the $459 annual threshold (CY2023). For purposes of this provision, an arrangement "approaches" the threshold when it would cause the aggregate to reach or exceed eighty percent (80%) of the annual limit;
(d) Proposed CME sponsorship from Pinnacle Laboratory Services Inc. or from any similarly situated entity with concurrent referral and equity-interest relationships with AHT or its officers, directors, or physicians.
D. Prohibited Items (Tier 4 — No Approval Possible)
The following items and interactions are prohibited under all circumstances. No level of approval can authorize these items, and any AHT personnel who engage in these activities are subject to disciplinary action, up to and including termination:
(a) Cash or cash equivalents provided to or received from referral sources at any dollar value, including but not limited to gift cards, prepaid debit cards, store credits, cryptocurrency, and similar instruments;
(b) Entertainment of referral sources or their immediate family members, as described in Section VI.A;
(c) Any gift, meal, or item of value that is expressly or implicitly conditioned on the volume or value of referrals or other business generated between AHT and the third party;
(d) Any gift, meal, or item of value that is solicited by a physician from a referral source or vendor. The non-monetary remuneration exception under Stark Law, 42 C.F.R. § 411.357(k), is unavailable for solicited items; moreover, soliciting items of value from referral sources or vendors creates an inherent appearance of impropriety;
(e) Items of value provided to immediate family members of physicians who are in a position to refer, where the purpose or effect of the provision is to influence or reward referrals. In this regard, the Company notes the potential sensitivity of arrangements involving immediate family members of AHT officers and directors. Specifically, Dr. Nathan Ellsworth (AHT Chief Executive Officer) and Dr. Karen Ellsworth are married; Dr. Karen Ellsworth holds a 4.2% passive equity interest in Pinnacle Laboratory Services Inc. Any items of value flowing directly or indirectly between AHT and Pinnacle must be analyzed with heightened scrutiny in light of this relationship, and all such arrangements must be disclosed to the CCO and General Counsel for independent review.
X. STATE-SPECIFIC REQUIREMENTS
In addition to federal law, AHT's operations are subject to state anti-kickback, referral fee, and gift restriction laws in each state in which the Company operates. This Section summarizes the key state-specific requirements applicable to AHT. Where a state law imposes a more restrictive standard than this Policy or federal law, the more restrictive standard governs.
A. Massachusetts (M.G.L. c. 175H, § 3)